Search - tctmd.com

Displaying 21 - 40 of 483

Sort: Relevancy | Date

News Conference News SCAI 2025

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

L.A. McKeown

May 02, 2025

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

L.A. McKeown

April 07, 2025

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

Presenter: Philippe Genereux

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

Projecting the Frequency of Failed Transcatheter Aortic Valves

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

Clinical Spotlight: Frequency and Consequences of Acute Valve Syndrome in Aortic Stenosis

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

First-in-Human Experience with the ModulHeart Device to Support Cardiorenal Function in Acute Decompensated Heart Failure with Diuretic Resistance (Puzzle Medical)

Presenter: Philippe Genereux

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

Presentation NY Valves 2024

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

June 07, 2024

Advertisement

Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

Pi-Cardia Reports First Commercial Cases with ShortCut™

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 651: Clinical Presentation Before Aortic Valve Replacement for Aortic Stenosis

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Keynote Lecture I: Rationale for Earlier Intervention in Aortic Stenosis: The Cardiac Damage Concept and Beyond

TCT 643: Cost Associated With the Extent of Cardiac Damage After Aortic Valve Replacement

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Projecting the Frequency of Failed Transcatheter Aortic Valves

Clinical Spotlight: Frequency and Consequences of Acute Valve Syndrome in Aortic Stenosis

First-in-Human Experience with the ModulHeart Device to Support Cardiorenal Function in Acute Decompensated Heart Failure with Diuretic Resistance (Puzzle Medical)

What’s Going to Be Big at TCT 2024?

Pi-Cardia Receives FDA Market Clearance for ShortCut™

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content